Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,528 | -3,530 | -2,920 | -1,776 | -2,543 |
| Depreciation Amortization | 77 | 47 | 17 | N/A | 259 |
| Other Working Capital | 2,171 | 1,327 | 668 | 611 | 263 |
| Other Operating Activity | 583 | 602 | 826 | 775 | 922 |
| Operating Cash Flow | $-1,697 | $-1,554 | $-1,410 | $-391 | $-1,099 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -37 | -9 | -9 | -9 | -10 |
| Other Investing Activity | -37 | -9 | -9 | -9 | -10 |
| Investing Cash Flow | $-37 | $-9 | $-9 | $-9 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,165 | 1,165 | 1,165 | 0 | 264 |
| Common Stock Issued | 600 | 600 | 600 | 450 | 950 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -233 |
| Financing Cash Flow | $1,765 | $1,765 | $1,765 | $450 | $981 |
| Beginning Cash Position | 42 | 42 | 42 | 42 | 170 |
| End Cash Position | 72 | 244 | 388 | 92 | 42 |
| Net Cash Flow | $31 | $202 | $346 | $50 | $-128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,697 | -1,554 | -1,410 | -391 | -1,099 |
| Free Cash Flow | -1,697 | -1,554 | -1,410 | -391 | -1,099 |